- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 116.36M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 115.43M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 140.97M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $117.8M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $101.7M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $817.5M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $819M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $353.5M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $353.2M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.12B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.03B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $623.7M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $644.9M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $642.9M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $942.8M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.13B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $998.4M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.1B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.98B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.41B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.29B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.73B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.63B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.28 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.28 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $14.7M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $17.4M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$32.4M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$11M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$25.2M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$15.5M |
| Revenue | Q1 2026 · Mar 31, 2026 | $382.4M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $398.2M |